14:49 Nov 05
Gland Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Gland Pharma Ltd.
46/100 Medium Financial Strength
Quality37/100 Mid Valuation
Valuation40/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
6
Opportunity
2
Threat
2
29.82K
Market Cap (Cr)
43.12
PE Ratio
3.04
Price to Book Ratio
35.01
RSI
13.63 %
Net Profit Margin
Rating Based on 2 Analysts
Buy
50%
Hold
50%
Sell
0%
Buy
Analyst Price Target
The average price target is 2220 with a high estimate of 2440 and low estimate of 2000
Current 1809.85
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
